Personality Traits in Patients Seeking a Consultation for Treatment for Floaters

Assessment of Personality Traits in Patients With Symptomatic Floaters Seeking Consultation for Its Treatment

This study aims to assess if certain personality traits are move prevalent in patients seeking consultation for treatment of floaters, despite good visual acuity and no other ocular pathology compared to the normal population.

Study Overview

• Status: Completed
• Conditions: Myodesopia
• Intervention / Treatment: Other: Big Five Questionnaire, Patient health questionnaire-9 and generalised anxiety disorder -7 questionnaire

Detailed Description

This study aims to assess if certain personality traits are move prevalent in patients seeking consultation for treatment of floaters, despite good visual acuity and no other ocular pathology compared to the normal population. A questionnaire utilising a validated personality trait assessment the 'Big Five Inventory' will collect information patients who have sought a consultation (or already had treatment in the form of vitrectomy) for floaters. We will also assess whether these patients are suffering from any degree of depression or anxiety using two validated screening questionnaires; the patient health questionnaire-9 to screen for depression, and the generalised anxiety disorder - 7 questionnaire to screen for anxiety. Identifying personality traits of patients who seek further help and potential therapeutic intervention, could help clinicians identify the individual factors that lead to this debilitating condition in some patients, despite having a healthy eye and may help determine future non-surgical minimally-interventional therapeutic approaches in the future

• Study Type: Observational
• Enrollment (Actual): 153

Contacts and Locations

Study Locations

• United Kingdom
  • Manchester, United Kingdom, M13 9WL
    • Manchester University NHS Foundation Trust

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 18 years and older (Adult, Older Adult)
• Accepts Healthy Volunteers: No
• Genders Eligible for Study: All

• Sampling Method: Non-Probability Sample

Study Population

Patients aged 18 or over who have contacted an Ophthlamologist for a consultation for treatment for myodesopia which has lasted more than 3 months

Description

Inclusion Criteria:

• • Patients aged 18 or over who have contacted an Ophthalmologist for a consultation for treatment for myodesopsia which has lasted for over 3 months

Exclusion Criteria:

• • Patients with co-existing ocular pathology e.g. uveitis, glaucoma, pathological myopia (refractive error > -6D)

  • Patients with cognitive impairment or learning difficulties that would affect their ability to access and complete the questionnaire
  • Patients with known personality disorders
  • Patients must be able to read, speak and understand English so they can comprehend the patient information sheet and questionnaire

Study Plan

How is the study designed?

Design Details

• Observational Models: Cohort
• Time Perspectives: Prospective

Number of groups / cohorts

1

Cohorts and Interventions

Group / Cohort	Intervention / Treatment
All patients will be given a questionnaire; All patients will be given the Big Five Questionnaire	Other: Big Five Questionnaire, Patient health questionnaire-9 and generalised anxiety disorder -7 questionnaire; Questionnaire

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Degree of neuroticism in patient group compared to an established normative database	Patients will complete a big five inventory questionnaire. This assesses five personality traits using a likert scale. There are 44 statements. The degree to which patients agree with each statement calculates their score, with certain statements being reversed scored. Patients indicate agreement by stating they either disagree strongly, disagree a little, neither agree nor disagree, agree a little or strongly agree. In items scored normally disagree strongly will give the minimum score of 1, with strongly agreeing giving a score of 5. For items which are reversed scored disagree strongly will give a score of 5, and strongly agreeing will give a score of 1.	6 months

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Difference in degree of other 4 personality measures in the big five inventory and normative database	The difference in extraversion, agreeableness, conscientiousness, openness in the recruited patient database and normative database will be analysed	6 months
Difference in degree of anxiety and depression between normative database and recruited patients	The patient health questionnaire -9 and generalised anxiety disorder questionnaire will be given to patients. These are commonly used tools to screen/assess depression and anxiety. With both questionnaires the higher the score, the greater the degree of anxiety or depression. The frequency of depression and anxiety within the patient group will be assessed and multivariate regression analysis will be done to see if there is an association with any of the personality traits.	6 months

Collaborators and Investigators

• Sponsor: Manchester University NHS Foundation Trust

Study record dates

Study Major Dates

• Study Start (Actual): December 15, 2021
• Primary Completion (Actual): August 3, 2022
• Study Completion (Actual): August 3, 2022

Study Registration Dates

• First Submitted: June 21, 2021
• First Submitted That Met QC Criteria: June 21, 2021
• First Posted (Actual): June 29, 2021

Study Record Updates

• Last Update Posted (Actual): August 31, 2022
• Last Update Submitted That Met QC Criteria: August 30, 2022
• Last Verified: August 1, 2022

More Information

Terms related to this study

• Other Study ID Numbers: 301344

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: Undecided

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No
• product manufactured in and exported from the U.S.: No